Anxiety can damage brain: Accelerate conversion to Alzheimer's for those with mild cognitive impairment

November 10, 2014
Credit: George Hodan/Public Domain

People with mild cognitive impairment (MCI) are at increased risk of converting to Alzheimer's disease within a few years, but a new study warns the risk increases significantly if they suffer from anxiety.

The findings were reported on Oct. 29 online by The American Journal of Geriatric Psychiatry, ahead of print publication, scheduled for May 2015.

Led by researchers at Baycrest Health Sciences' Rotman Research Institute, the study has shown clearly for the first time that anxiety symptoms in individuals diagnosed with MCI increase the risk of a speedier decline in cognitive functions - independent of depression (another risk marker). For MCI patients with mild, moderate or severe anxiety, Alzheimer's risk increased by 33%, 78% and 135% respectively.

The research team also found that MCI patients who had reported anxiety symptoms at any time over the follow-up period had greater rates of atrophy in the medial temporal lobe regions of the brain, which are essential for creating memories and which are implicated in Alzheimer's.

Until now, anxiety as a potentially significant risk marker for Alzheimer's in people diagnosed with MCI has never been isolated for a longitudinal study to gain a clearer picture of just how damaging anxiety symptoms can be on cognition and brain structure over a period of time. There is a growing body of literature that has identified late-life depression as a significant risk marker for Alzheimer's. Anxiety has historically tended to be subsumed under the rubric of depression in psychiatry. Depression is routinely screened for in assessment and follow-up of memory clinic patients; anxiety is not routinely assessed.

"Our findings suggest that clinicians should routinely screen for anxiety in people who have memory problems because anxiety signals that these people are at greater risk for developing Alzheimer's," said Dr. Linda Mah, principal investigator on the study, clinician-scientist with Baycrest's Rotman Research Institute, and assistant professor in the Department of Psychiatry at the University of Toronto. Dr. Mah is also a co-investigator in a multi-site study lead by the Centre for Addiction and Mental Health, and partially funded by federal dollars (Brain Canada), to prevent Alzheimer's in people with late-life depression or MCI who are at high risk for developing the progressive brain disease.

"While there is no published evidence to demonstrate whether drug treatments used in psychiatry for treating anxiety would be helpful in managing anxiety symptoms in people with or in reducing their risk of conversion to Alzheimer's, we think that at the very least behavioural stress management programs could be recommended. In particular, there has been research on the use of mindfulness-based stress reduction in treating anxiety and other psychiatric symptoms in Alzheimer's —and this is showing promise," said Dr. Mah.

The Baycrest study accessed data from the large population-based Alzheimer's Disease Neuroimaging Initiative to analyze anxiety, depression, cognitive and brain structural changes in 376 adults, aged 55 - 91, over a three-year period. Those changes were monitored every six months. All of the adults had a clinical diagnosis of amnestic MCI and a low score on the depression rating scale, indicating that were not part of clinical .

MCI is considered a risk marker for converting to Alzheimer's disease within a few years. It is estimated that half-a-million Canadians aged 65-and-older have MCI, although many go undiagnosed. Not all MCI sufferers will convert to Alzheimer's - some will stabilize and others may even improve in their cognitive powers.

The Baycrest study has yielded important evidence that anxiety is a "predictive factor" of whether an individual with MCI will convert to Alzheimer's or not, said Dr. Mah. Studies have shown that in MCI is associated with abnormal concentrations of plasma amyloid protein levels and T-tau proteins in cerebrospinal fluid, which are biomarkers of Alzheimer's. Depression and chronic stress have also been linked to smaller hippocampal volume and increased risk of dementia.

Explore further: Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia

Related Stories

How is depression related to dementia?

July 30, 2014

A new study by neuropsychiatric researchers at Rush University Medical Center gives insight into the relationship between depression and dementia. The study is published in the July 30, 2014, online issue of Neurology, the ...

Recommended for you

Gene discovered associated with Tau pathology

March 24, 2017

Investigators at Rush University Medical Center and the Brigham and Women's Hospital in Boston reported the discovery of a new gene that is associated with susceptibility to a common form of brain pathology called Tau that ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

SoapboxJill
not rated yet Nov 10, 2014
Both cognitive damage and anxiety are symptoms of radiofrequency radiation disruption of normal brain functions. See youtube presentation on blood brain barrier leakage from exposure to electromagnetic fields by Dr. Leif Salford.

To understand the magnitude of degenerative damage the increasing manmade radiofrequency radiation is doing as we speak, esp. to the fetus and the young, see the MD Symposium at C4ST, where scientists/experts reveal what wireless is doing via the mechanisms of damage.

To ignore this science because a tech is fun / convenient means many will pay. Think asbestos, lead paint, tobacco, thalidomide. Are you ready to sacrifice your loved ones to the wireless god?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.